Somatic Mutations in DCC Are Associated with Genomic Instability and Favourable Outcomes in Melanoma Patients Treated with Immune Checkpoint Inhibitors

The authors performed an integrated study based on biological experiments and multi-dimensional data types, including genomic, transcriptomic, and clinical immune checkpoint blockade-treated melanoma cohorts from public databases.